Wednesday, 19 February 2020

China News

  • Tiyanyin pharma all set for GMP inspection

    China |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 15 Jul, 2014

    Singapore: China-based Tianyin Pharmaceutical is looking ahead to get its Qionglai Facility (QLF) GMP certified post insepction by China Food and Drug Administration (CFDA) expected to begi...Read more

  • Industry applauds Dr Weidong Yin

    China |  Influencers | By BioSpectrum Bureau  | 0 Comment | 15 Mar, 2012

    "I met Dr Weidong Yin for the first time in 1996 when I went to Tangshan, China. At that time, he was involved in research. He was very young then and was running a very small scale company...Read more

  • Simcere, Zhuhai enter share transfer agreement

    China |  News | By BioSpectrum Bureau  | 0 Comment | 26 Jun, 2013

    Singapore: Leading pharmaceutical company, Simcere Pharmaceutical, announced sale of equity interest in Jilin Bodapharmaceutical (Boda). The company entered into a share transfer agreement ...Read more

  • SFDA reports high chromium in Biostar's drug

    China |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore, June 01, 2012: China based Biostar Pharmaceuticals has acknowledged the finding of  chromium content higher than edible gelatin from a batch of its Xin Aoxing capsules following...Read more

  • US biotech firm invests in China to enter Asia

    China |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore, June 01, 2012: GenScript, a US biotech company, has announced the opening of a new R&D facility in Nanjing, China. This new facility will play a key role in GenScript's strat...Read more

  • Ambrx, Zhejiang, WuXi to develop cancer drug in China

    China |  News | By BioSpectrum Bureau  | 0 Comment | 17 Jun, 2013

    Singapore: US-based Ambrx and China-based Zhejiang Medicine (ZMC) announced that they have formed a collaboration to develop and commercialize ARX788, Ambrx's most advanced internally devel...Read more

  • CCBC continues to repurchase shares

    China |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: China Cord Blood, the first and largest cord blood banking operator in China, repurchased an aggregate of 2,191,412 ordinary shares for a total consideration of approximately $6...Read more

  • A great leader'

    China |  News | By BioSpectrum Bureau  | 0 Comment | 19 Mar, 2012

    "Dr Wang has great vision for Sundia and her leadership makes it possible for us to see tremendous growth. She has successfully led Sundia to navigate through the global financial crisis in...Read more

  • 'China's H7N9 outbreak an epidemic'

    China |  News | By BioSpectrum Bureau  | 0 Comment | 17 Mar, 2014

    Singapore: While experts and health ministries in various Chinese provinces have declared the on-going second wave of H7N9 in the country as more destructive than the first one in early 201...Read more